Charles Perou, PhD, and colleagues have classified breast cancers into 12 distinct biological groups. This could aid future research efforts and enable faster translation of molecular findings into the pathology lab for clinical use, they report. https://t.co/Qc1FWgkMGF
Win 2 tickets to see @DukeMBB play The Citadel on Monday, 11/22! Raffle sales end tonight and proceeds support local MBC research! https://t.co/CxcFLZ3N63
.@SusanGKomen has awarded three grants in support of metastatic breast cancer research as part of a collaboration between Komen, UNC Lineberger and @DukeCancer. https://t.co/VFfoEnfwZg #MBCCollab
"I am still alive and thriving today because a relatively new treatment was available to me when I was first diagnosed. What I know is that it is science that has prolonged my life," @PamLKohl, who is living with metastatic breast cancer. #MBCCollab
Though COVID-19 continues to be a major health focus, we
ask that you still encourage those you love to schedule their
mammograms and other important screenings. Early
screening can save lives! Find nearby locations by visiting:
https://t.co/B8IweRsuwA
#screenoutcancer30
Our partner @BlueCrossNC is supporting #breastcancer survivors at the Drive for the Cure 250! Submit your signature to be included on the pace car and be entered to win a VIP experience with 2 free tickets! https://t.co/YRwyOZF4Ng
Komen is launching Stand for H.E.R.- a Health Equity Revolution, to decrease breast cancer disparities in the Black community by 25% beginning in the US metropolitan where inequities are greatest. Join us in taking action today. https://t.co/ieurNi8MO8
McDonnell's project will assess the effectiveness of targeting AGR2 and LYPD3 as a new potential combination therapy for metastatic Estrogen Receptor (ER)-positive breast cancer. https://t.co/YNfLnh2IaE
The $14 million in new grants support our mission to end #breastcancer through funding two key focus areas: research to better detect and treat stage IV (metastatic) breast cancer and research to eliminate disparities in breast cancer outcomes. https://t.co/3ZWqOGydgN
Congratulations to Dr. Melissa Troester of @UNC_Lineberger for being named a Komen Scholar! Your #breastcancer research in North Carolina inspires us every day.
Komen welcomed six esteemed researchers and three patient advocates to leadership roles. The women and men were chosen for their knowledge, leadership, scientific expertise and guidance and are committed to reducing death and suffering from #breastcancer. https://t.co/UbnFhUVcQ8
SAVE THE DATE 📅 for next year's #KomenTri - Saturday, April 30, 2022!
As we begin planning, please share your thoughts on the 2021 virtual experience and what you'd like to see at the live event through this survey: https://t.co/BtCIB1D7vl
THANK YOU for supporting #breastcancer research, support, care, and advocacy through our 25th anniversary #KomenTri locally presented by @DukeCancer! We appreciate everyone that registered, donated, fundraised, and engaged virtually this spring 👏